These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16239763)

  • 1. Dopaminergic contribution to the regulation of emotional perception.
    Salgado-Pineda P; Delaveau P; Blin O; Nieoullon A
    Clin Neuropharmacol; 2005; 28(5):228-37. PubMed ID: 16239763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine and the regulation of cognition and attention.
    Nieoullon A
    Prog Neurobiol; 2002 May; 67(1):53-83. PubMed ID: 12126656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic modulation of oscillatory network inhibition in the rat basolateral amygdala depends on initial activity state.
    Ohshiro H; Kubota S; Murakoshi T
    Neuropharmacology; 2011 Sep; 61(4):857-66. PubMed ID: 21683087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction.
    Laviolette SR; Grace AA
    Cell Mol Life Sci; 2006 Jul; 63(14):1597-613. PubMed ID: 16699809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotensin: role in psychiatric and neurological diseases.
    Cáceda R; Kinkead B; Nemeroff CB
    Peptides; 2006 Oct; 27(10):2385-404. PubMed ID: 16891042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action.
    Jentsch JD; Roth RH; Taylor JR
    Prog Brain Res; 2000; 126():433-53. PubMed ID: 11105661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The principal features and mechanisms of dopamine modulation in the prefrontal cortex.
    Seamans JK; Yang CR
    Prog Neurobiol; 2004 Sep; 74(1):1-58. PubMed ID: 15381316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine: a key regulator to adapt action, emotion, motivation and cognition.
    Nieoullon A; Coquerel A
    Curr Opin Neurol; 2003 Dec; 16 Suppl 2():S3-9. PubMed ID: 15129844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic modulation of amygdala activity during emotion recognition in patients with Parkinson disease.
    Delaveau P; Salgado-Pineda P; Witjas T; Micallef-Roll J; Fakra E; Azulay JP; Blin O
    J Clin Psychopharmacol; 2009 Dec; 29(6):548-54. PubMed ID: 19910719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of levodopa on healthy volunteers' facial emotion perception: an FMRI study.
    Delaveau P; Salgado-Pineda P; Wicker B; Micallef-Roll J; Blin O
    Clin Neuropharmacol; 2005; 28(6):255-61. PubMed ID: 16340378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders.
    Nikolaus S; Antke C; Müller HW
    Behav Brain Res; 2009 Dec; 204(1):32-66. PubMed ID: 19523495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intra-accumbens dopaminergic grafts on behavioral deficits induced by 6-OHDA lesions of the nucleus accumbens or A10 dopaminergic neurons: a comparison.
    Herman JP; Choulli K; Abrous N; Dulluc J; Le Moal M
    Behav Brain Res; 1988 Jul; 29(1-2):73-83. PubMed ID: 3401324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apomorphine in the evaluation of dopaminergic function in man.
    Lal S
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(2-3):117-64. PubMed ID: 3290992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neurodevelopmental role of dopaminergic signaling in neurological disorders.
    Cai Y; Xing L; Yang T; Chai R; Wang J; Bao J; Shen W; Ding S; Chen G
    Neurosci Lett; 2021 Jan; 741():135540. PubMed ID: 33278505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep brain stimulation of the subthalamic nucleus enhances emotional processing in Parkinson disease.
    Schneider F; Habel U; Volkmann J; Regel S; Kornischka J; Sturm V; Freund HJ
    Arch Gen Psychiatry; 2003 Mar; 60(3):296-302. PubMed ID: 12622663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging in Parkinson's disease: the role of monoamines in behavior.
    Brooks DJ; Piccini P
    Biol Psychiatry; 2006 May; 59(10):908-18. PubMed ID: 16581032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine electrophysiology of ventral pallidal/substantia innominata neurons: comparison with the dorsal globus pallidus.
    Napier TC; Simson PE; Givens BS
    J Pharmacol Exp Ther; 1991 Jul; 258(1):249-62. PubMed ID: 1677041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The dopamine transporter: characterization and physiopathologic implications].
    Thibaut F; Vaugeois JM; Petit M
    Encephale; 1995; 21(6):445-51. PubMed ID: 8674469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine modulation of emotional processing in cortical and subcortical neural circuits: evidence for a final common pathway in schizophrenia?
    Laviolette SR
    Schizophr Bull; 2007 Jul; 33(4):971-81. PubMed ID: 17519393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of the nucleus accumbens in psychiatric disorders].
    Mavridis I
    Psychiatriki; 2015; 25(4):282-94. PubMed ID: 26709994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.